Results 121 to 130 of about 3,671 (210)

Comparative analysis of whole spine and sacroiliac joint magnetic resonance SPARCC scores in patients with SAPHO syndrome and ankylosing spondylitis. [PDF]

Front Immunol
Shen Y, Gu X, Yang J, Zhou M, Lin Z, Wang R, Liu J, Guo M, Li C, Zhu Q, He D.   +10 more
europepmc   +1 more source

Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees. [PDF]

Ther Adv Musculoskelet Dis
Juárez-García M, Plasencia-Rodríguez C, Benavent D, Díaz-Almirón M, Novella-Navarro M, Tornero C, Peiteado D, Juanola X, Moreno M, de Miguel E, Gratacós J, Navarro-Compán V.   +11 more
europepmc   +1 more source

Biologic and targeted synthetic therapies in ankylosing spondylitis: a pharmacological review. [PDF]

Front Pharmacol
Ameer OZ, Temsah R, Alsouss YO, Al-Amoudi R, Khanfar MA, Salman IM.   +5 more
europepmc   +1 more source

Immune Regulatory Endotypes Defined by TRIM-Dependent Ubiquitin Signaling and IFN-NF-κB Network Activity in Ankylosing Spondylitis. [PDF]

Int J Mol Sci
Dogan SC, Agbektas T, Atas M, Kabak G, Tas A, Silig Y.   +5 more
europepmc   +1 more source

IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence. [PDF]

Ther Adv Musculoskelet Dis
Paci V, Foti R, Pantano I, Carletto A, Celletti E, Miceli GF, Cangemi I, Lopalco G, Montalbano S, Chimenti MS, Picchianti Diamanti A, Massafra U, Filippucci E, Parisi A, Leccese P, Panaccione A, Puca I, Amato G, Marrone S, Di Penta M, Corrao S, Cela E, Rai A, Tirri E, Iannone F, Atzeni F, Rossini M, Ciccia F, Foti R, Moroncini G, Luchetti Gentiloni MM.   +30 more
europepmc   +1 more source

Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE). [PDF]

RMD Open
Vladimirova N, Østergaard M, Seven S, Møller JM, Jensen B, Østgård R, Poggenborg R, Madsen OR, Hendricks O, Brix L, Georgiadis S, Pedersen SJ.   +11 more
europepmc   +1 more source

Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab. [PDF]

Arthritis Res Ther
Vladimirova N, Østergaard M, Georgiadis S, Seven S, Møller JM, Jensen B, Østgård R, Poggenborg R, Madsen OR, Hendricks O, Brix L, Pedersen SJ.   +11 more
europepmc   +1 more source

Interrelations of disease activity, health-related quality of life, and mental health in axial spondyloarthritis: the Rheuma-VOR cohort. [PDF]

Front Med (Lausanne)
Schiestl LJ, Wendt E, Proft F, Hoeper K, Witte T, Assmann G, Schwarting A, Dreher M.   +7 more
europepmc   +1 more source

Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies. [PDF]

Front Med (Lausanne)
Qiu Z, Chen Z, Yang Z, Xia R, Chen W, Zhu Y, Wang W, Li Z, Yang K.   +8 more
europepmc   +1 more source

Potential association between IL-17A inhibition and blood pressure reduction in patients with axial spondyloarthritis. [PDF]

Front Immunol
Wu Q, Wang Y, Zhao T, Guo J, Zhang X, Tu Y, Wang F.   +6 more
europepmc   +1 more source